These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9024567)
21. Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome. Gofflot F; Kolf-Clauw M; Clotman F; Roux C; Picard JJ Am J Med Genet; 1999 Nov; 87(3):207-16. PubMed ID: 10564872 [TBL] [Abstract][Full Text] [Related]
22. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661 [TBL] [Abstract][Full Text] [Related]
23. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome. Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563 [TBL] [Abstract][Full Text] [Related]
24. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. Keller RK; Arnold TP; Fliesler SJ J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996 [TBL] [Abstract][Full Text] [Related]
25. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Paila YD; Murty MR; Vairamani M; Chattopadhyay A Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059 [TBL] [Abstract][Full Text] [Related]
26. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome. Ruan B; Tsai J; Wilson WK; Schroepfer GJ J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346 [TBL] [Abstract][Full Text] [Related]
27. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome. Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201 [TBL] [Abstract][Full Text] [Related]
28. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Waterham HR; Wanders RJ Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101 [TBL] [Abstract][Full Text] [Related]
29. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations. Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416 [TBL] [Abstract][Full Text] [Related]
30. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082 [TBL] [Abstract][Full Text] [Related]
31. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome. Fliesler SJ; Vaughan DK; Jenewein EC; Richards MJ; Nagel BA; Peachey NS Pediatr Res; 2007 Mar; 61(3):273-8. PubMed ID: 17314682 [TBL] [Abstract][Full Text] [Related]
32. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention. Fliesler SJ; Xu L Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379 [TBL] [Abstract][Full Text] [Related]
33. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Xu L; Sheflin LG; Porter NA; Fliesler SJ Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966 [TBL] [Abstract][Full Text] [Related]
34. Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts. Shefer S; Salen G; Honda A; Batta A; Hauser S; Tint GS; Honda M; Chen T; Holick MF; Nguyen LB Metabolism; 1997 Jul; 46(7):844-50. PubMed ID: 9225842 [TBL] [Abstract][Full Text] [Related]
35. The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis. Tint GS; Batta AK; Xu G; Shefer S; Honda A; Irons M; Elias ER; Salen G Subcell Biochem; 1997; 28():117-44. PubMed ID: 9090293 [No Abstract] [Full Text] [Related]
36. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis. Battaile KP; Steiner RD Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806 [TBL] [Abstract][Full Text] [Related]
37. [Smith-Lemli-Opitz syndrome; a special defect in cholesterol metabolism]. Aalfs CM; Hennekam RC; Wanders RJ; Jira PE; Pilon JW; Wijburg FA Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1463-6. PubMed ID: 8766772 [TBL] [Abstract][Full Text] [Related]
38. Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome. Merkens LS; Connor WE; Linck LM; Lin DS; Flavell DP; Steiner RD Pediatr Res; 2004 Nov; 56(5):726-32. PubMed ID: 15319461 [TBL] [Abstract][Full Text] [Related]
40. A patient with Smith-Lemli-Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement. Szabó GP; Oláh AV; Kozak L; Balogh E; Nagy A; Blahakova I; Oláh E Eur J Pediatr; 2010 Jan; 169(1):121-3. PubMed ID: 19365639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]